| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human CD300a/LMIR1 Fc Chimera Protein, CF |
|---|
| Description | Purity >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. MW (observed): 60-80 kDa, reducing conditions. MW (theoretical): 44.0 kDa (monomer). The Recombinant Human CD300a/LMIR1 Fc Chimera Protein from R&D Systems is derived from NS0. The Recombinant Human CD300a/LMIR1 Fc Chimera Protein has been validated for the following applications: Bioactivity. |
|---|
| Size | 50 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Bioactivity |
|---|
| Other Names | CD300a, CD300a antigenCMRF35H9, CD300a molecule, CLM8, CLM-8, CMRF-35H, CMRF35-H, CMRF35H leukocyte immunoglobulin-like receptor, CMRF35-H9, CMRF-35-H9CD300 antigen-like family member A, CMRF35HIRp60, CMRF35-like molecule 8, IgSF12, IGSF12NK inhibitory receptor, Immunoglobulin superfamily member 12, Inhibitory receptor protein 60, IRC1, IRC1/IRC2, IRC2, IRp60, leukocyte membrane antigen, LMIR1, MAIR-I, Mcipr1, NKRL, Pigr4 |
|---|
| Gene, Accession, CAS # | CD300A, Gene ID: 11314, Accession: Q9UGN4 |
|---|
| Catalog # | 2640-LM-050 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human CD300a/LMIR1 Fc Chimera Protein, CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|